Xenetic Biosciences, Inc. (XBIO)
Develops cancer drugs that block immune cells from protecting tumors.
$2.45-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-23.8%
The outlook
XBIO is trading near the bottom of its 52-week range and sits below both its 50- and 200-day moving averages, reflecting weak recent momentum. Analyst coverage appears sparse based on available data. The current price sits well below longer-term trend levels.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$5.6M
52-wk high
$13.93
52-wk low
$1.90
50-day avg
$2.95
200-day avg
$2.89
Trailing P/E
—